Clin2
NCT07175506Likely a fitRecruiting

Study of cm559 in healthy volunteers

Healthy Subjects

This trial tests a new drug called CM559 in healthy people to see if it is safe. If you are between 18 and 60 years old and generally healthy, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You must be between 18 and 60 years old.
  • You must be in good general health.
  • You cannot smoke more than 5 cigarettes a day on average in the last 3 months.
  • You must not drink heavily or be unable to avoid alcohol during the study.
  • You cannot have a history of drug abuse in the past year.
  • You cannot have donated blood or lost more than 400 mL of blood in the last 12 weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07560033Not yet recruiting· Phase 1
Study of CM326 in Healthy Men

This study tests how a new investigational drug (called CM326) behaves in the body of healthy volunteers. It is a pharmacokinetic study, meaning it looks at how the drug is absorbed, distributed, and eliminated. Participation may help researchers understand the drug's safety and dosing for future studies.

NCT07292688Recruiting· Phase 1
Testing a new antibody drug in healthy adults

This trial tests a new investigational drug called CM383, which is a type of antibody (a protein that helps the immune system) possibly targeting brain plaque linked to Alzheimer's disease. It is an early-stage study in healthy volunteers to check safety and how the drug behaves in the body.

Hangzhou
NCT07823764Not yet recruiting· Phase 1
Testing a new antibody drug in healthy volunteers

This trial tests a new antibody drug called CM583 in healthy people to see if it is safe and how the body handles it. It may help treat conditions related to certain proteins involved in pain and inflammation.

Hangzhou, Zhejiang
NCT07660341Recruiting· Phase 1
Study of CGB3002 in healthy volunteers

This trial tests a new drug, CGB3002, to see how safe it is and how the body processes it. Healthy volunteers are needed to help determine the right dose and check for side effects.

Melbourne, Victoria
NCT06612970Recruiting· Phase 1
Single dose study of HB0056 in healthy adults

This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.

Christchurch
NCT06577337Recruiting· Phase 1
Testing a new drug (M5542) in healthy volunteers

This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.

Neu-Ulm

Hear when a new Healthy Subjects trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.